Contents    Prev    Next    Last


            Title United States ex rel. Merena v. SmithKline Beecham Corporation

 

            Date 2000

            By Alito

            Subject Misc

                

 Contents

 

 

Page 1





LEXSEE 205 F3D 97


UNITED STATES OF AMERICA EX REL. ROBERT J. MERENA v. SMITHKLINE BEECHAM CORPORATION; United States of America, Appellant; UNITED STATES OF AMERICA EX REL. KEVIN J. SPEAR; THE BERKELEY COMMUNITY LAW CENTER; JACK DOWDEN v. SMITHKLINE BEECHAM CLINICAL LABORATORIES, INC.; United States of America, Appellant; UNITED STATES OF AMERICA EX REL. GLENN GROSSENBACHER; CHARLES W. ROBINSON, JR. v. SMITHKLINE BEECHAM CLINICAL LABORATORIES, INC.; United States of America, Appellant


No. 98-1497, No. 98-1498, No. 98-1499


UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT



205 F.3d 97; 2000 U.S. App. LEXIS 2948


March 5, 1999, Argued

February 29, 2000, Filed


SUBSEQUENT HISTORY:   **1   As Amended April

21, 2000.


PRIOR HISTORY: ON APPEAL FROM THE UNITED STATES  DISTRICT  COURT  FOR  THE  EASTERN DISTRICT OF PENNSYLVANIA. (Dist. Ct. Nos. 93-cv--

5974 and 95-cv--6551). District Judge:  The Honorable

Donald W. VanArtsdalen. DISPOSITION: Reversed and remanded. LexisNexis(R) Headnotes



COUNSEL:  Douglas  N.  Letter,  Freddi  Lipstein  (ar- gued),   United   States   Department   of   Justice,   Civil Division,  Appellate Staff,  Washington,  D.C.,  Attorneys for Appellant United States of America.


Marc S. Raspanti (argued),  Miller,  Alfano & Raspanti, Philadelphia,   PA,   Attorney   for   Appellee   Robert   J. Merena.


Thomas   H.   Lee,                 II,   Dechert,           Price   &   Rhoads, Philadelphia,   PA,   Attorney   for   Appellee   Smithkline Beecham.


Normand   F.   Pizza,   Nyda   S.   Brook,   Christopher   J. Shenfield, Brook, Pizza, & Van Loon, New Orleans, LA, Attorneys for Appellee William, St. John & LaCorte.


John E. Clark, Goode, Casseb & Jones, San Antonio TX, Attorney  for  Appellees  Charles  W.  Robinson,  Jr.,  and Glenn Grossenbacher.



Peter  W.  Chatfield,   Phillips  &  Cohen,   Washington, DC,  Attorney  for  Appellees  Kevin  J.  Spear,  Berkeley Community Law Center, and Jack Dowden.


Carol S. Dew, Dew & Smith, Monroe, GA, Attorney for

Appellee Jeffrey Clausen.


Lisa  R.  Hovelson,   Taxpayers  Against  Fraud,             **2  Washington D.C., Attorney for Amicus Curiae Taxpayers Against Fraud, The False Claims Act Legal Center.


Daniel  Popeo,   Paul  D.  Kamenar,   Washington  Legal Foundation,  Washington,  Attorneys  for  Amicus  Curiae Washington Legal Foundation.


JUDGES: Before: ALITO, McKEE, AND GARWOOD,

* Circuit Judges.


* The Honorable Will L. Garwood, Senior Circuit Judge for the United States Court of Appeals for the Fifth Circuit, sitting by designation.


OPINIONBY: ALITO


OPINION:

*98   OPINION OF THE COURT ALITO, Circuit Judge:


In this appeal, the United States challenges the District Court's  decision  to  award  a  group  of  qui  tam  rela- tors approximately $52 million of the government's set- tlement  with  defendant  SmithKline  Beecham  Clinical


205 F.3d 97, *98; 2000 U.S. App. LEXIS 2948, **2

Page 2



Laboratories of a variety of claims under the False Claims Act, 31 U.S.C. § 3729 et seq. For the reasons explained below, we reverse and remand for further proceedings.


I.


A. In 1992,  the United States began to suspect that SmithKline Beecham Clinical Laboratories ("SKB") and several other medical laboratories had adopted the follow- ing scheme that allowed them to bill the federal govern- ment for unauthorized and unnecessary laboratory tests.

**3   The laboratories had "bundled" a standard group- ing of blood tests with some additional tests and had then marketed this grouping to doctors by leading them to be- lieve  that  the  additional  tests  would  not  increase  costs to Medicare and other government-sponsored health pro- grams.


After the tests were ordered, the laboratories "unbun- dled" the additional tests from the standard grouping for purposes of billing. In many instances, treating physicians had made no determination that the additional tests were medically necessary for the diagnosis   *99   or treatment of patients; instead, the physicians had ordered the tests solely because they were sold as a package with other tests that they had deemed necessary. As a result, the laborato- ries submitted bills--and received payment--for tests that were medically unnecessary.


This scheme, which later became known as the "au- tomated chemistry" scheme, attracted national attention in December 1992 when one of the contractors that had engaged  in  the  practice,  National  Health  Laboratories, settled a lawsuit brought under the False Claims Act for

$111 million. See Joint App. at 1432-1441. Public interest grew as the news **4   media reported that the govern- ment had issued comprehensive subpoenas to SKB and other laboratories. See Joint App. at 1442-1450, 1451-

1457, 1470-1473.


B.  In  November  1993,  relator  Robert  Merena,  an SKB  employee,  filed  a  qui  tam  action  against  SKB  in the United States District Court for the Eastern District of Pennsylvania. His complaint contained eight separate claims under the False Claims Act. Merena's complaint alleged that SKB had defrauded the government by, in- ter alia, billing for tests that were not performed, double billing, paying illegal kickbacks to health care profession- als, and adding tests to "automated chemistry" profiles and then separately billing for those tests. App. at 75-103.


One  month  later,  relator  Glenn  Grossenbacher,  an attorney,  filed  a  second  qui  tam  action  against  SKB  in the United States District Court for the Western District of  Texas.  n1  Relators  Kevin  Spear,  Jack  Dowden,  and the Berkeley Community Law Center (collectively, "the Spear relators") followed in February of 1995 with a suit



in the Northern District of California. The courts in Texas and  California  transferred  these  actions  to  the  Eastern District of Pennsylvania for consolidation with **5   the Merena case.


n1 In August 1995, Dr. Charles Robinson, a for- mer SKB medical director in San Antonio, joined the Grossenbacher complaint.



After Merena's action was filed, the government com- menced an investigation into a series of new claims that were  not  part  of  its  original  investigation. At  the  same time, the government continued to pursue the original "au- tomated chemistry" investigation that it had begun after the 1992 settlement with National Health Laboratories.


C.  In  August  1995,  the  government  began  formal settlement negotiations with SKB. The government pre- sented SKB with a written settlement framework that al- located  a  specific  dollar  amount  for  each  alleged  false claim. Joint App. at 1476-1491.


By early 1996, SKB and the government had reached a  tentative  agreement  to  settle,  for  $295  million,  cer- tain federal and state claims for losses occurring through December 31, 1994. This agreement was intended to set- tle claims related to the government's original "automated chemistry"  investigation,  along   **6               with  additional claims  in  the  qui  tam  actions  filed  by  relators  Merena, Grossenbacher,  and  Spear.  At  a  meeting  on  March  22,

1996, counsel for the United States explained to the rela- tors the components of the proposed settlement. See Joint App. at 1537, 1538-1549. During the summer of 1996, the United States negotiated an additional payment from SKB of $30 million to resolve additional claims that arose during 1995 and 1996. Joint App. at 859, 1223.


The government formally intervened in the Merena, Grossenbacher, and Spear actions pursuant to 31 U.S.C.

§ 3730(b)(2). Soon thereafter, the District Court formally approved  a  settlement  agreement  between  the  United States and SKB for $325 million plus interest. See Joint App. at 201-221. Although the False Claims Act provides a specific mechanism for relators to challenge the ade- quacy of a settlement agreement into which the govern- ment enters,   *100   31 U.S.C. § 3730(c)(2)(B), Merena, Grossenbacher, and the Spear relators did not challenge the overall statement. See Joint App. at 213.


After approving the settlement agreement, the District

Court dismissed the three qui tam actions with prejudice.

**7   However, the Court expressly retained jurisdiction over, among other things, the "determination of the rela- tors' qui tam shares." Dist. Ct. Op. At 7. See Joint App. at

198, 274-277.


205 F.3d 97, *100; 2000 U.S. App. LEXIS 2948, **7

Page 3



The  District  Court  subsequently  disposed  of  com- plaints  that  three  other  relators  filed  after  the  Merena, Grossenbacher,  and  Spear  complaints.  The  Court  ana- lyzed these complaints on a claim-by--claim basis in or- der to determine whether each claim was barred under the

"first-to--file"  rule  imposed  by  31  U.S.C.  §  3730(b)(5). The Court was able to identify only one claim that had not been raised in one of the previously filed complaints. Accordingly, the Court allowed that claim to survive but barred all the others. The later-filing relators appealed, but we affirmed the District Court's decision. See United States  ex  rel.  LaCorte  v.  SmithKline  Beecham  Clinical Lab., 149 F.3d 227, 235-236 (3d Cir. 1998).


The  government  failed  to  reach  an  agreement  with relators Merena and Grossenbacher on the amount that they would receive from the settlement agreement. The government maintained that Merena was entitled to ap- proximately $10 million of the $65 million attributable to the **8   non-"automated chemistry" claims and has paid Merena this amount. The government and the Spear relators have a proposed agreement that, if approved, will award the Spear relators 15% of the $13 million that the government attributed to a claim called the "CBC Indices" claim.


D. The core of the current dispute between the United

States and relators Merena, Grossenbacher, and Robinson

(hereinafter "the relators") concerns the relators' right to a share of the settlement proceeds attributable to the "au- tomated chemistry" claims. The relators argue that they are entitled under  31 U.S.C. § 3170(d) to a percentage of the total proceeds that the government obtained in the settlement. The government, on the other hand, maintains that the relators may not receive any portion of the pro- ceeds  attributable  to  the  "automated  chemistry"  claims because the relators' "automated chemistry" claims were jurisdictionally barred under the public-disclosure provi- sion of the qui tam statute,  31 U.S.C. § 3730(e)(4) ("sec- tion(e)(4)"), which provides that "no court shall have ju- risdiction" over any False Claims Act action that is "based upon" certain specified **9    public disclosures unless the action is brought by the Attorney General or an "origi- nal source" of the information. The government contends that the District Court lacked subject matter jurisdiction over the relators' "automated chemistry" claims and, ac- cordingly, could not grant them any share of the settlement allocable to those claims.


The  District  Court  held  an  evidentiary  hearing  re- garding this dispute. The government presented evidence concerning  the  portion  of  the  total  settlement  that  was attributable to each claim. n2 The government also pre- sented evidence showing that the "automated chemistry" claims had been under investigation, and were widely re-



ported in the news media, long before any of the qui tam complaints were filed. Joint App. at 2159-2160, 2204.


n2 The government also presented evidence that the relators had actively participated in the alloca- tion process. See Joint App. at 1476-1491.



In an unpublished opinion, the District Court accepted the relators' position. The Court denied the government's

**10   motion to dismiss the relators' "automated chem- istry" claims under 31 U.S.C. § 3730(e)(4),  noting that the qui tam complaints had already been dismissed with prejudice and " did  not have to be re-dismissed." Dist.

*101    Ct.  Op.  At  36.  Agreeing  with  the  relators  that the question of subject matter jurisdiction was "mooted" when the government formally intervened in the action, the  Court  declined  to  decide  whether  the  relators'  "au- tomated  chemistry"  claims  would  have  been  subject  to dismissal  prior  to  the  government's  intervention.  Id.  at

36-37.


The  Court  also  rejected  the  government's  argument that it was necessary to analyze the relators' complaints on a claim-by--claim basis in order to calculate their shares. Id. at 37-43. The Court observed:


The qui tam statute involved makes no men- tion of treating a qui tam complaint as having distinct and divisible claims for the purpose of  determining  the  qui  tam  Relator's  share of  the  proceeds.  The  statute  provides  that where the Government intervenes and pro- ceeds with the action, as it did in these cases, the qui tam Relator shall "receive at least 15 percent but no more than 25 percent of the proceeds of the action **11  or settlement of the claim." (Underlining added). The statute speaks of the action and claim as a single unit or whole entity.


Dist. Ct. Op. at 38. In addition, the Court noted that the government had "never sought to have any of the relators' qui tam allegations dismissed prior to the entry of the or- der settling and dismissing each of the actions with preju- dice," that the government had never sought leave to file an amended complaint, and that the Settlement Agreement and related filings did not break down the settlement on a claim-by--claim basis. Id. at 38-39. Furthermore,  the Court stated that "there was  absolutely no evidence on the record . . . to establish any allocation." Id. at 41. See also id. at 42 ("Even if dividing the proceeds among sep- arate claims would be appropriate, there is no evidence upon  which  a  fact-finder  could  rationally  make  such  a determination on the record before me.") The Court con-


205 F.3d 97, *101; 2000 U.S. App. LEXIS 2948, **11

Page 4




cluded that the relators were entitled under 31 U.S.C. §

3170(d) to between 15% and 25% of approximately $306 million. n3 After considering the contributions made by the  relators,  the  Court  decided  that  they  should  jointly receive n4 an award **12   of 17% of the proceeds -- or more than $52 million. Since the government had already paid Merena about $10 million, the Court entered an or- der awarding the relators approximately $42 million. The United States appealed.


n3 This sum was calculated as follows: the set- tlement proceeds plus interest (about $334 million) minus both the total paid to state Medicaid Fraud units (about $14.5 million) and the agreed alloca- tion to the Spear relators (about $13 million).


n4  The  Court  found  it  unnecessary  to  decide whether either the Merena or Grossenbacher com- plaint  was  barred  under  the  first-to--file  rule  of

§  3730(b)(5)  because  these  relators  had  "agreed among  themselves  as  to  the  division  of  any  pro- ceeds,  regardless  to  whom  the  award  or  awards were made." Dist. Ct. Op. at 69.



II.


This appeal requires us to decide two chief legal is- sues.  The  first  concerns  the  application  of  the  relevant provisions of the qui tam statute to a multi-count com- plaint. The second concerns the interpretation of section

3170(e)(4)   **13    and its relationship to the provision governing awards to relators in cases in which the United States  elects  to  proceed  with  the  action,  31  U.S.C.  §

3170(d). We will discuss each of these issues and then apply our conclusions to the particular situation presented in this case.


A.  As  we  have  previously  commented,  the  drafts- mans hip of the qui tam statute has its quirks, see United States ex rel. Mistick v. Housing Authority of the City of Pittsburgh,  186  F.3d  376,  387  (3d  Cir.  1999),  and  one of those quirks is that the statute is based on the model of a single-claim complaint. See id. The District Court in this case stated:  "It would seem almost inevitable to me that at least in most qui tam actions there would be allegations   *102   of multiple false claims alleged in a complaint," Dist. Ct. Op. At 38, and we are inclined to agree, but the qui tam statute is phrased as if every qui tam complaint contained only one claim. The following provisions illustrate this pattern.


The statute authorizes a qui tam plaintiff to bring a

"civil action for a violation of section 3729," 31 U.S.C.

§ 3730 (b)(1)(emphasis added), but surely such **14   a plaintiff may bring an action containing multiple claims,



each of which alleges a separate violation of section 3729. When  a  qui  tam  action  is  filed,  the  government  may

"proceed  with  the  action,"  §§  3730(b)(2)  and  (4)(em- phasis  added)  or  "decline  to  take  over  the  action,"  §

3730(b)(4)(B)(emphasis added), but the government of- ten decides to take over only certain claims in a multi- claim action,  and we are aware of no decision holding that this is improper. The statute authorizes the govern- ment to "dismiss the action" and "settle the action," 31

U.S.C. § 3730(c)(2)(A) and (B), but again, we are aware of no decision holding that the government may not settle or dismiss only some of the claims in a multi-claim com- plaint, and we can think of no reason why the government should not be permitted to do so.


Under  the  "first-to--file"  rule  of  section  3730(b)(5), when a relator "brings an action," "no other person may .

. . bring a related action based on the facts underlying the pending action." But as the District Court's prior rulings in this case illustrate, when it is asserted that a later-filed complaint contains claims that are based on the facts un- derlying certain **15   claims in a pending multi-count complaint, the court must conduct a claim-by--claim anal- ysis in order to determine if section 3730(b)(5) applies. Section  3730(e),  provides  that  no  court  shall  have jurisdiction  over  "an  action"  that  falls  into  one  of  four categories: (1) "an action" brought by a former or present member  of  the  armed  forces  against  a  member  of  the armed forces arising out the plaintiff 's military service,

(2) "an action" against a member of Congress or the ju- diciary  or  a  senior  executive  branch  official  if  "the  ac- tion" is based on evidence or information known to the Government,  (3)"an  action"  based  upon  allegations  or transactions that are the subject of a civil suit or certain administrative proceedings to which the government is a party, and (4) "an action" based on certain publicly dis- closed information (unless the action is brought by the Attorney General or an original source). What happens under these provisions if a relator files a multi-claim suit and some, but not all, of the claims fall into one of these categories?  The plaintiff 's decision to join all of his or her claims in a single lawsuit should not rescue claims that would have been doomed by section **16   (e)(4) if they had been asserted in a separate action. And likewise, this joinder should not result in the dismissal of claims that would have otherwise survived.


Thus,  in applying section (e)(4),  it seems clear that each claim in a multi-claim complaint must be treated as if it stood alone. It follows, therefore, that in determining whether  the  relators  in  this  case  are  entitled  to  a  share of  any  proceeds  that  are  attributable  to  the  "automated chemistry" claims, we must consider whether they would have been entitled to such a share had their complaints


205 F.3d 97, *102; 2000 U.S. App. LEXIS 2948, **16

Page 5



asserted those claims alone. We now turn to that question. B. The government contends that the relators are not entitled to any share of the proceeds attributable to the "au- tomated chemistry" claims because those claims are based upon publicly disclosed information and fall within the ju- risdictional bar of § 3170(e)(4). The government reasons as follows: the District Court lacked subject matter juris- diction over the relators' automated chemistry claims; n5 therefore, the Court could not award them any recovery.


n5  Although  Section  3730(e)(4)  is  framed  in jurisdictional terms,  the Seventh Circuit has sug- gested that it does not really concern subject mat- ter jurisdiction. See United States ex rel. Fallon v. Accudyne Corp., 97 F.3d 937, 941 (7th Cir. 1996). For  the  reasons  explained  in  the  text,  we  find  it unnecessary to resolve this question.


**17


*103    Perhaps  because  the  government  couches its argument in terms of subject matter jurisdiction, the District Court and the relators respond in similar terms. Both argue that any jurisdictional problem that might have existed with respect to the "automated chemistry" claims when the relators' complaints were originally filed was cured when the government elected to proceed with those claims. They note --  and the government does not dis- agree --  that the District Court had subject matter juris- diction over the "automated chemistry" claims, as well as the other claims,  once the government intervened. And the  relators  also  rely  on  an  old  series  of  cases  in  our circuit,  n6  which  they  interpret  to  mean  that  even  if  a relator's claim is originally subject to a jurisdictional bar, intervention  by  the  government  cures  the  jurisdictional defect. The government replies by attempting to draw a distinction between jurisdiction over the automated chem- istry claims as prosecuted by the United States on its own behalf  after  intervention  (which  the  government  agrees the District Court had) and jurisdiction over those same claims as they concerned the relators after intervention

(which the government strenuously **18   contends the District Court lacked). According to the government, the District  Court's  lack  of  the  second  type  of  jurisdiction mandated the dismissal of the relators as parties with re- spect to the automated chemistry claims.


n6  In  chronological  order  they  are:   United

States ex rel. Bayarsky v. Brooks, 58 F. Supp. 714

(D.N.J.  1945);  United  States  ex  rel.  Bayarsky  v. Brooks, 154 F.2d 344 (3d Cir. 1946); United States ex rel. Bayarsky v. Brooks, 110 F. Supp. 175 (D.N.J.

1953); United States ex rel. Bayarsky v. Brooks, 210

F.2d 257 (3d Cir. 1954).





We do not agree with the parties that the relators' right to a share of the automated chemistry proceeds turns on a question of subject matter jurisdiction. n7 Suppose that the government is right that the District Court should have dismissed the relators as parties with respect to the auto- mated chemistry claims. It would not necessarily follow that the relators could not be awarded a share of the auto- mated chemistry **19   proceeds. Congress may enact a statute providing for the payment of a reward or bounty to a non-party who assists the government's enforcement ef- forts. See, e.g., 15 U.S.C. § 78u-1. Similarly, suppose that the relators are right that the government's intervention cured any prior jurisdictional defect and that the District Court properly refused to dismiss the relators as parties with respect to the automated chemistry claims. It would not necessarily follow that the relators are entitled to a share of the proceeds. Clearly, Congress need not provide for such relators to obtain a portion of the proceeds just because they remain parties.


n7  Although  Section  3730(e)(4)  is  framed  in jurisdictional terms,  the Seventh Circuit has sug- gested that it does not really concern subject matter.



The  relevant  question  is  not  one  of  jurisdiction  but simply whether the qui tam statute authorizes an award when a relator asserts a claim that is subject to dismissal under  §  3170(e)(4)  but  the  government   **20              inter- venes  before  the  claim  is  dismissed.  In  order  to  ana- lyze this question it is necessary to examine both section

3730(e)(4) and section 3730(d).


Section 3730(e)(4) provides as follows:


(A) No court shall have jurisdiction over an action under this section based upon the pub- lic  disclosure  of  allegations or  transactions in  a  criminal,  civil,  or  administrative  hear- ing,  in  a  congressional,  administrative,  or Government Accounting Office report, hear- ing, audit, or investigation, or from the news media,  unless  the  action  is  brought  by  the Attorney General or the person bringing the action is an original source of the informa- tion.

*104

(B) For purposes of this paragraph, "original source" means an individual who has direct and independent knowledge of the informa- tion on which the allegations are based and has voluntarily provided the information to the Government before filing an action under


205 F.3d 97, *104; 2000 U.S. App. LEXIS 2948, **20

Page 6



this section which is based on the informa- tion.


Thus, if a relator who is not an "original source" as- serts a claim based upon one of the types of public dis- closure specified in this provision n8 and the government does not intervene, the claim must be dismissed, and the relator obviously **21   receives no award. This provi- sion does not expressly address the question whether such a relator is entitled to an award if the government inter- venes before the relator's claim is dismissed -- although it certainly counsels in favor of skepticism about a relator's ability to get an award under those circumstances.


n8 In United States ex rel. Mistick v. Housing

Authority of the City of Pittsburgh, 186 F.3d at 385-

89, we held that a claim is "based upon" a public disclosure if it is based upon information contained in such a disclosure, whether or not the relator ac- tually relied upon that disclosure.



Other sections of the qui tam statute deal directly with awards to relators. Under section 3730(d)(2), if the gov- ernment does not intervene,  a relator is entitled to 25-

30% of the proceeds. But if the government intervenes

(and thus takes on the primary burden of prosecuting the action), the share to which the relator is entitled is reduced as specified in section 3730(d)(1). This provision states in **22   pertinent part:


If the Government proceeds with an action brought  by  a  person  under  subsection  (b), such person shall, subject to the second sen- tence  of  this  paragraph,  receive  at  least  15 percent but not more than 25 percent of the



proceeds  of  the  action  or  settlement  of  the claim,  depending upon the extent to which the  person  substantially  contributed  to  the prosecution of the action. Where the action is one which the court finds to be based pri- marily on disclosures of specific information

(other than information provided by the per- son  bringing  the  action)  relating  to  allega- tions or transactions in a criminal,  civil,  or administrative  hearing,  in  a  congressional, administrative,  or  Government  Accounting Office report, hearing, audit, or investigation, or from the news media, the court may award such sums as it considers appropriate, but in no case more than 10 percent of the proceeds, taking into account the significance of the in- formation and the role of the person bringing the action in advancing the case to litigation. Any payment to a person under the first or second  sentence  of  this  paragraph  shall  be made from the proceeds.


The parties in this appeal differ sharply **23  regard- ing the types of cases that fall within the various recovery ranges. The government,  as previously noted,  takes the position  that  a  relator  who  asserts  a  claim  that  is  sub- ject to dismissal under section 3730(e)(4) is not entitled to  any  award  even  if  the  government  intervenes.  Thus, the government's view is that section 3730(d)(1) has no application  in  such  a  case.  If  the  government's  view  is accepted, we believe that the permissible ranges of recov- ery for various types of cases is captured by the following table:





TABLE A Relator's Share   Types of Cases


15-25%   1. relator brings an action that is

not "based upon" publicly disclosed information

2. "original source" brings an action that is "based upon" but not

"primarily based" on publicly disclosed information

3. "original source" brings an action that is "primarily based" on publicly disclosed information, but the

"original source" did not provided the information

</=10%   "original source" brings an action


205 F.3d 97, *104; 2000 U.S. App. LEXIS 2948, **23



TABLE A Relator's Share   Types of Cases

that is "primarily based" on publicly disclosed information, and

"original source" did not provide that information

0%           relator brings an action that is subject to dismissal under

§ 3730(e)(4)

Page 7





*105   The **24   relators read sections 3730(e)(4) and 3730(d) quite differently. As already mentioned, they contend  that  section  3730(e)(4)  does  not  preclude  an award where a relator asserts a claim that is subject to dis- missal under that section but the government intervenes before the claim is dismissed. The award in such a case





consequently would be governed by Section 3730(d). If the relators' position is accepted, we believe that the per- missible recovery ranges for the various types of cases would be as follows:





TABLE B Relator's Share    Types of Cases


15-25%   1. relator brings an action that is

not "based upon" publicly disclosed information

2. relator brings an action that is

"based upon" but not "primarily based" upon publicly disclosed information

3. relator brings an action that is

"primarily based" upon publicly disclosed information but relator provided the information

</=10%   relator brings an action that is

"primarily based" upon publicly disclosed information, and the relator did not provide the information





We find the government's position much more persua- sive. Under this view, sections 3730(e)(4) and 3730(d)(1) provide  a  descending  scale  of  recovery   **25    ranges that are proportional to the public service provided by the relators. The highest range (15-25%) is reserved for the relators who provide the greatest public service--relators whose claims are not "based upon" a public disclosure and most relators who qualify as "original sources." The lesser range (up to 10% of the proceeds) is provided for the

(presumably unusual) cases in which an "original source"

relator  asserts  a  claim  that  is  "primarily  based"  on  in-





formation that has been publicly disclosed and that the relator did not provide.


In contrast with the government's position, the rela- tors' position produces results that we do not think that Congress intended. First, this interpretation provides a po- tentially huge windfall -- 15-25% of the total recovery -- for most relators whose claims would have been dismissed under section 3730(e)(4) if the government had not inter- vened. It is hard to see why Congress might have wanted the fortuity of government intervention to make such a


205 F.3d 97, *105; 2000 U.S. App. LEXIS 2948, **25

Page 8



difference -- or why Congress might have wanted to pro- vide such a large reward to such a relator, who provides little if any public service. See Federal Recovery Service, Inc. v. United States,  72 F.3d 447,  452 (5th Cir. 1995)

**26    (describing a similar interpretation as "ignoring the False Claims Act's goal of preventing parasitic suits based on information discovered by others" and as requir- ing awards in "even those suits  brought by individuals who discovered the defendant's fraud by reading about it in the morning paper").


Second,   the  relators'  interpretation  prescribes  the same range of awards -- 15-25% -- for two very dissimi- lar groups of relators:  first, those relators who provide a substantial public service by bringing claims that are not based upon publicly disclosed information and, second, relators who furnish little if any public service because their  claims  are  "based  upon"  publicly  disclosed  infor- mation n9 and would have been dismissed under section

3730(e)(4) if the government had not intervened. It seems unlikely that Congress wanted these two vastly different types of relators to be treated the same.


n9 But not "primarily based" upon such infor- mation.



Third,   the  relators'  interpretation  treats  original- source relators **27   the same as other relators whose claims are based on publicly disclosed information. Under the relators' interpretation,  if a relator's claim is "based upon" (but not "primarily based"   *106   upon) publicly disclosed information, the relator is entitled to 15-25% regardless  of  whether  the  relator  is  an  original  source. Since  Congress  took  pains  in  section  3730(e)(4)(B)  to provide special,  favorable treatment for original-source relators, it seems unlikely that Congress wanted a rela- tor's original-source status to be irrelevant in determining the award that a relator receives in a case in which the government intervenes.


The legislative history also supports the government's view. As Table A illustrates, under the government's inter- pretation, the 0% - 10% range applies only when an "orig- inal source" brings a claim that is "primarily based" on publicly disclosed information and the "original source" did not provide that information. By contrast,  as previ- ously  noted,  under  the  relators'  view,  this  range  is  not restricted to "original-source" relators. In discussing the provision of § 3730(d) creating the 0% - 10% range, two of  the  primary  sponsors  of  the  1986  False  Claims  Act amendments  described   **28    the  cases  to  which  this range would apply, and both stated clearly that this range would apply only to "original sources." Senator Grassley stated:





When the qui tam plaintiff brings an action based on public information, meaning he is an "original source" within the definition un- der the act, but the action is based primarily on public information not originally provided by the qui tam plaintiff, he is limited to a re- covery of not more than 10 percent. In other words  a  10-percent  cap  is  placed  on  those

"original sources" who bring cases based on information already publicly disclosed where only an insignificant amount of that informa- tion stemmed from that original source.

132 Cong. Rec. 28580 (1986) (emphasis added). Similarly, Representative Berman commented:


The only exception to the  minimum 15% recovery is in the case where the information has  already  been  disclosed  and  the  person qualifies  as  an  "original  source"  but  where the essential elements of the case were pro- vided to the government or news media by someone other than the qui tam plaintiff.


132 Cong. Rec. 29322 (1986). These statements pro- vide  strong  support  for  our  interpretation  of  §§   **29

3730(d)(1) and (e)(4).


For all these reasons, we conclude that a relator whose claim is subject to dismissal under section 3730(e)(4) may not receive any share of the proceeds attributable to that claim.


III


Thus far, we have concluded that the relators' share of the proceeds must be based on a claim-by--claim anal- ysis  and  that  the  relators  are  not  entitled  to  any  share of the settlement attributable to claims that would have been subject to dismissal under section 3730(e)(4) prior to the government's intervention. These holdings do not necessarily dictate reversal, however, because the District Court also held (a) that the government waived its right to argue that the relators were not entitled to recover a share of the proceeds attributable to the "automated chemistry" claims and (b) that the government did not offer sufficient evidence to establish the share of the proceeds attributable to those claims. We now consider those issues.


A. The District Court held that, when the government agreed to settle the lawsuit,  it waived its right to argue that  the  relators  were  barred  from  recovering  proceeds attributable to the automated chemistry claims. Dist. Ct. Op. at 36-37. We disagree.   **30


The  settlement  agreement  between  the  government


205 F.3d 97, *106; 2000 U.S. App. LEXIS 2948, **30

Page 9



and SKB did not dispose of any issues pertaining to the relators' share of the settlement proceeds. The agreement expressly stated that the parties would "request" that the District Court "specifically retain jurisdiction with respect

*107   to any unresolved issues, including . . . relators' share of the settlement proceeds." Joint App. at 214. The Court's order dismissing the actions stated:  "this Court retains jurisdiction over . . . determination of . . . rela- tors' share issues." Joint App. at 198. Therefore,  by its own terms, the settlement agreement preserved the gov- ernment's right to contest the issue of the relators' share. Accordingly, we hold that the District Court erred in con- cluding  that  the  government  waived  its  right  to  argue that  the  relators  were  barred  from  recovering  proceeds attributable to the automated chemistry claims.


B. The District Court also held that it had no factual basis upon which to determine the percentage of the set- tlement that was attributable to the automated chemistry claims. See Dist. Ct. Op. at 41 ("There is absolutely no evidence  on  the  record  before  me  .  .  .  to  establish  any allocation among various **31   claims."). The District Court  blamed  the  supposed  dearth  of  evidence  on  the government,  suggesting that the government refused to provide any meaningful response to the relators' discov- ery requests concerning the factual basis for its allocation of the settlement proceeds. Id. at 42-43.


The District Court's conclusion is not supported by the record. The record shows that the government produced substantial evidence related to the allocation of the set- tlement proceeds. During an evidentiary hearing before the  District  Court,  the  government  introduced  a  series of documents--created during the government's negotia- tions with SKB--that specified the amount of money the government had demanded for each alleged violation of the False Claims Act. See Joint App. at 1474, 1475-1491. These documents showed that approximately $241 mil- lion were attributable to the automated chemistry claims. The relators, on the other hand, failed to present any evi- dence. By declining to present evidence contradicting the government's allocation of the settlement proceeds,  the relators  effectively  gave  up  their  right  to  challenge  the factual basis of that allocation.


Having reviewed the record, we are satisfied **32  that the government submitted sufficient evidence to en- able the District Court to allocate the settlement proceeds on a claim-by--claim basis. Accordingly, we conclude that the District Court's finding--i.e., that there was "no ev- idence" upon which to determine the percentage of the settlement that was attributable to the automated chem- istry claims--was clearly erroneous. n10



n10 We make no determination with respect to the exact percentage of the settlement that must be attributed to the automated chemistry claims;  we simply hold that the District Court had an adequate factual basis for making such a finding.



IV.


It  is  beyond  dispute  that,  under  our  circuit's  inter- pretation  of  Section  3730(e)(4)  in  Mistick,  186  F.3d  at

385-89,  the  relators'  automated  chemistry  claims  were

"based  upon"  a  public  disclosure  specified  in  that  pro- vision. See Joint App. at 1432-1441, 1442-1450, 1451-

1457,  1470-1473;  1492-1498. As we explained above, relators who bring such a claim cannot recover any pro- ceeds attributable **33   to that claim unless they qualify as original sources of information under section (e)(4)(B). The District Court therefore erred in allowing the relators to recover proceeds attributable to the "automated chem- istry"  claims  without  determining  whether  the  relators were "original sources."


On remand, the District Court must determine whether the relators were "original sources" of information--as de- fined by section (e)(4)(B)--with respect to the "automated chemistry" claims. If the District Court determines that they were original sources of information, it may award them a share of the proceeds and will have to determine whether they fall within the 15-25%   *108   range or the

0-15% range as set out in Table A supra. n11 However, if  the  District  Court  determines  that  the  relators  were not original sources of information with respect to those claims, it may not award them any share of the proceeds attributable to them.


n11 We express no view as to whether the Court may properly award any recovery jointly to the per- tinent relators, or whether it must specify each re- lator's award. Consideration of this issue would be premature until (a) it is determined under the correct legal standard that a relators' award is appropriate and (b) the issue is properly brought before us by a party with standing.


**34  V.


For the foregoing reasons, we hold that the District Court erred in awarding the relators 17% of the settlement proceeds. Accordingly, we reverse and remand for further proceedings consistent with this opinion.


Contents    Prev    Next    Last


Seaside Software Inc. DBA askSam Systems, P.O. Box 1428, Perry FL 32348
Telephone: 800-800-1997 / 850-584-6590   •   Email: info@askSam.com   •   Support: http://www.askSam.com/forums
© Copyright 1985-2011   •   Privacy Statement